Delayed torsades de pointes after massive risperidone overdose with rising paliperidone concentrations: a case report

The human heart beats with a rhythm that depends on a delicate electrical balance. For the heart to pump blood effectively, its muscle cells must charge and discharge in a precise sequence, a process that leaves a measurable trace on an electrocardiogram known as the QT interval. When this interval stretches too long, the electrical system can stumble, leading to a chaotic, swirling rhythm called torsades de pointes. This dangerous condition can cause the heart to stop pumping, requiring immediate medical intervention to restore order. Certain medications, including those used to treat severe mental health conditions, are known to interfere with this electrical balance. While doctors understand that these drugs can sometimes lengthen the QT interval, the specific circumstances under which a massive overdose leads to a fatal rhythm disturbance remain difficult to predict. This uncertainty is particularly true when the body breaks down a drug into other substances, or metabolites, that might behave differently than the original pill.

A team of researchers at the National Hospital Organization Disaster Medical Center and Saitama Medical University recently documented a rare and complex case that sheds light on this hidden danger. They followed a woman in her forties with schizophrenia who arrived at the emergency department after stabbing her own abdomen and swallowing a massive amount of risperidone, an antipsychotic medication. Initially, the medical team focused on her physical trauma. She had lost a significant amount of blood and required emergency surgery to stop the bleeding, followed by a massive transfusion of blood products to stabilize her. For the first several hours, her condition appeared to improve. Her vital signs stabilized, and her heart rhythm seemed manageable. However, nine and a half hours after she was admitted, her heart suddenly slipped into the dangerous, swirling rhythm known as torsades de pointes. She required cardiopulmonary resuscitation and a dose of epinephrine to restart her heart.

The medical team treated the immediate crisis with magnesium sulfate, a mineral that helps calm the heart's electrical activity, and a temporary pacemaker to keep the heart beating at a steady, faster pace. While the patient eventually recovered and was transferred to a psychiatric facility, the doctors were left with a puzzling question: why did the heart failure happen so late, long after the initial trauma and surgery had been managed? Further investigation revealed that the woman had not just taken the 40 tablets initially found at the scene, but had ingested more than 700 milligrams of risperidone. To understand the timing of her heart failure, the researchers measured the levels of the drug and its breakdown products in her blood over time.

The data revealed a striking and counterintuitive pattern. When the woman first arrived at the hospital, her blood contained an extraordinarily high level of risperidone, measuring 1,185.86 nanograms per milliliter. As time passed, this level began to drop, which is what one would expect as the body processes and eliminates a drug. However, her blood levels of paliperidone, the active substance the body creates when it breaks down risperidone, continued to rise. By the time her heart went into the dangerous rhythm, the level of the original risperidone had fallen to 683.05 nanograms per milliliter, but the level of paliperidone had climbed to a peak of 1,320.83 nanograms per milliliter. The researchers calculated that the original drug was clearing from her system at a rate that suggested a half-life of about 10 hours, while the metabolite lingered with a half-life of nearly 23 hours.

This case suggests that the delayed heart failure was not caused by the initial shock of the overdose or the surgery alone, but by the slow accumulation of the metabolite. Even though the amount of the original drug in her blood was decreasing, the amount of the active breakdown product was increasing, eventually reaching a level high enough to trigger the dangerous heart rhythm. The authors note that the patient's body was under immense stress from blood loss and surgery, which may have altered how her liver and kidneys processed the chemicals, but the timing of the heart trouble aligns perfectly with the rise of the metabolite. This finding challenges the assumption that a patient is safe once the initial drug levels begin to fall. It indicates that in cases of massive overdose, the body can continue to generate toxic levels of active substances long after the initial ingestion, creating a delayed window of extreme risk.

The researchers emphasize that this specific sequence of events, where a metabolite peaks after the parent drug declines to cause a fatal rhythm, has not been clearly described before in such a severe overdose. They point out that while the patient survived, the situation highlights the need for medical teams to monitor heart rhythms for a much longer period than usual after a massive overdose, even if the patient seems stable. The treatment used in this case, magnesium and pacing, proved effective in stabilizing her heart, but the key lesson lies in the timing. The heart did not fail because the drug was still at its highest concentration, but because the body's own processing of that drug created a new, delayed peak of toxicity. This case serves as a reminder that the story of a drug overdose does not end when the pill is swallowed or when the initial symptoms fade; the body's internal chemistry can continue to evolve, creating dangers that appear hours later.